Sensing/pacing lead complications with a newer generation implantable cardioverter-defibrillator: Worldwide experience from the guardian ATP 4210 clinical trial
Bruce S. Stambler, Mark A. Wood, Ralph J. Damiano, Patricia S. Greenway, Mark L. Smutka, Kenneth A. Ellenbogen
Dive into the research topics of 'Sensing/pacing lead complications with a newer generation implantable cardioverter-defibrillator: Worldwide experience from the guardian ATP 4210 clinical trial'. Together they form a unique fingerprint.